中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

HBV相关慢加急性肝衰竭预后简易评分系统的建立

厉新妍 黄淑琳 方亮 雷瑞祥 柯伟民

引用本文:
Citation:

HBV相关慢加急性肝衰竭预后简易评分系统的建立

DOI: 10.3969/j.issn.1001-5256.2014.10.006
基金项目: 

广州市医药卫生科技项目(201102A213093); 广东省医学科学技术研究基金(A2011472); 

详细信息
  • 中图分类号: R575.3

A simple scoring system for evaluating severity of HBV-related acute-on-chronic liver failure

Research funding: 

 

  • 摘要:

    目的建立HBV相关慢加急性肝衰竭(HBV-ACLF)严重度简易评分系统。方法收集620例HBV-ACLF患者的临床资料,选择肝性脑病、血清肌酐、血清总胆红素、凝血酶原活动度、感染、肝脏大小、腹水液平等7个临床指标,应用统计学方法并结合临床实际,确定各指标从04分评分界点,并累计总分。据此建立模型并确定诊断界点,对此评分模型进行验证。结果对HBV-ACLF患者临床资料进行统计学分析,交互卡方检验确定各指标评分分值并建立模型。将500例患者分为生存组和死亡组。两组间评分差异有统计学意义(t=25.78,P<0.001)。受试者工作特征曲线(ROC曲线)下面积0.963,最佳临界值9.5,灵敏度0.98,特异度0.83。120例患者对其进行验证,≥10分预后差,病死率为84.3%,≤9分组预后好,病死率为3.5%。两组病死率比较差异有统计学意义(χ2=72.2,P<0.001)。结论本评分系统可用于HBV-ACLF预后评估,具有简易、敏感、客观的优点。

     

  • [1]LUO KX.Hepatitis B basic biology and clinical science[M].Third Edition.Beijing:People's Health Publishing House, 2006:246. (in Chinese) 骆抗先.乙型肝炎基础和临床[M].3版.北京:人民卫生出版社, 2006:246.
    [2]ZHANG DQ, CHEN L, GAN QR, et al.Prognostic factors for hepatitis B acute-on-chronic liver failure[J].J Clin Hepatol, 2012, 28 (10) :740-743. (in Chinese) 张冬青, 陈立, 甘巧蓉, 等.乙型肝炎相关慢加急性肝衰竭患者的预后因素分析[J].临床肝胆病杂志, 2012, 28 (10) :740-743.
    [3]LI JF, DUAN ZP.Acute–on-chronic liver failure:from pathophysiology to clinical practice[J].J Clin Hepatol, 2013, 29 (9) :641-644. (in Chinese) 李俊峰, 段钟平.慢加急性肝衰竭:从病理生理到临床实践[J].临床肝胆病杂志, 2013, 29 (9) :641-644.
    [4]LEE WM, STRAVITZ RT, LARSON AM.Introduction to the revised American association for the study of liver disease position paper on acute liver failure[J].Hepotology, 2012, 55 (3) :965-967.
    [5]SUN XJ, YE JF, FU Y, et al.Long-term management of the successful adult liver transplant:2012 Practice Guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation[J].J Clin Hepatol, 2013, 29 (6) :Ⅰ-ⅩⅤ. (in Chinese) 孙晓军, 叶军锋, 付裕, 等.美国肝病学会和美国移植学会2012年实践指南:成人肝移植成功后的长期管理[J].临床肝胆病杂志, 2013, 29 (6) :Ⅰ-ⅩⅤ.
    [6]BENTEN D, STERNECK M, PANSE J, et al.Low recurrence of preexisting extrahepatic malignancies after liver transplantation[J].Liver Transpl, 2008, 14 (6) :789-798.
    [7]Liver Failure and Artificial Liver Group, Chinese Society of InfectiousDiseases, Chinese Medical Association;Severe Liver Diseasesand Artificial Liver Group, Chinese Society of Hepatology, ChineseMedical Association.Diagnostic and treatment guidelines for liver failure[J].Chin J Hepatol, 2006, 14 (9) :643-646. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊疗指南[J].中华肝脏病杂志, 2006, 14 (9) :643-646.
    [8]PUGH RN, MURRAY-LYON M, DAWSON JL, et al.Transection of the oesophagus for bleeding oesophageal varices[J].Br J Surg, 1973, 60 (8) :646-649.
    [9]KAMATH PS, WIESNER RH, MALINCHOC M, et al.A model to predict survival in patients with end-stage liver disease[J].Hepatology, 2001, 33 (2) :464-470.
    [10]MAARTEN W, GLENN M, PHILIP A, et al.The Kidney[M]∥BRADY HR.ARF in association with liver disease.Philadelphia:WB Saunders, 2000:1234.
    [11]BOTTA F, GIANNINI E, ROMAGNOLI P, et al.MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function:a European study[J].Gut, 2003, 52 (1) :134-139.
    [12]ZHOU J, YE JM, WANG XL, et al.Predictive values of three indexes on short-term prognosis in patients with liver failure treated by artificial liver support system[J/CD].Chin J Crit Care Med:Electronic Edition, 2011, 4 (1) :13-18. (in Chinese) 周健, 叶俊茂, 王雪丽, 等.三种评价指标在肝衰竭患者人工肝治疗短期预后中的作用[J/CD].中华危重症医学杂志:电子版, 2011, 4 (1) :13-18.
  • 加载中
计量
  • 文章访问数:  2780
  • HTML全文浏览量:  20
  • PDF下载量:  617
  • 被引次数: 0
出版历程
  • 收稿日期:  2014-03-17
  • 出版日期:  2014-10-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回